Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03014726 · ClinicalTrials.gov registry record · Early Phase 1
ROBUST I Pilot Study, Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease
A Early Phase 1 study, sponsored by Urotronic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 53
- Enrollment target
NCT03014726 is a Early Phase 1 study that has completed, run by Urotronic. The registered enrollment target is 53 participants.
The verdict
NCT03014726, a Early Phase 1 study, has completed, sponsored by Urotronic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 53 participants
- Enrollment target
Study Summary
Robust I study is a feasibility study for evaluating the safety and efficacy of DCB.
Interventions
- COMBINATION_PRODUCT Urotronic Drug Coated Balloon (DCB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2016-11 |
| Est. Completion | 2023-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03014726
The ClinicalTrials.gov registry entry for NCT03014726 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Urotronic, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Urotronic Drug Coated Balloon (DCB) is the first listed.
NCT03014726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03014726 about?
NCT03014726 is a clinical study titled "ROBUST I Pilot Study, Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease". Robust I study is a feasibility study for evaluating the safety and efficacy of DCB.
What is the current status of trial NCT03014726?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 53 participants. The study started on 2016-11. Estimated completion is 2023-04.
What interventions are being tested in trial NCT03014726?
The interventions under investigation include: Urotronic Drug Coated Balloon (DCB) (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03014726?
This trial is sponsored by Urotronic, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.